AKT1 and neoplasm: Dysregulation of this pathway is common in various cancers, with activated PI3K/AKT signaling associated with multiple processes, including the induction of tumor cell proliferation, inhibition of apoptosis, and promotion of invasion and metastasis (Yang et al. 2019).